LU40963A1 - - Google Patents

Info

Publication number
LU40963A1
LU40963A1 LU40963DA LU40963A1 LU 40963 A1 LU40963 A1 LU 40963A1 LU 40963D A LU40963D A LU 40963DA LU 40963 A1 LU40963 A1 LU 40963A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU40963A1 publication Critical patent/LU40963A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
LU40963D 1961-08-16 1961-12-15 LU40963A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB63662A DE1157734B (de) 1961-08-16 1961-08-16 Verfahren zur Herstellung von haltbaren, oral zu verabreichenden Poliomyelitisvirus-Praeparaten

Publications (1)

Publication Number Publication Date
LU40963A1 true LU40963A1 (xx) 1962-02-15

Family

ID=6974088

Family Applications (1)

Application Number Title Priority Date Filing Date
LU40963D LU40963A1 (xx) 1961-08-16 1961-12-15

Country Status (6)

Country Link
DE (1) DE1157734B (xx)
FI (1) FI40401B (xx)
FR (1) FR2084M (xx)
GB (1) GB989077A (xx)
LU (1) LU40963A1 (xx)
SE (1) SE303173B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR041880A1 (es) * 2002-11-01 2005-06-01 Glaxosmithkline Biolog Sa Composicion inmunogena

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine

Also Published As

Publication number Publication date
DE1157734B (de) 1963-11-21
FR2084M (xx) 1963-10-21
GB989077A (en) 1965-04-14
SE303173B (xx) 1968-08-19
FI40401B (xx) 1968-09-30

Similar Documents

Publication Publication Date Title
BE625616A (xx)
BE601744A (xx)
BE396226A (xx)
BE458606A (xx)
BE464928A (xx)
BE469342A (xx)
BE472265A (xx)
BE475425A (xx)
BE12203A (xx)
BE476407A (xx)
BE478349A (xx)
BE482264A (xx)
BE493336A (xx)
BE567723A (xx)
BE568568A (xx)
BE583834A (xx)
BE587184A (xx)
BE596839A (xx)
BE597352A (xx)
BE597570A (xx)
BE598861A (xx)
BE599016A (xx)
BE599210A (xx)
BE599528A (xx)
BE599922A (xx)